PES2020-Prosj.etabl.støtte H2020
Development of a novel medication for treatment of drug refractory childhood epilepsy
Theracule is developing a new turmeric oil-derived therapeutic for the treatment of drug-refractory childhood epilepsy.
The main compound, TCA-01, is sourced from the turmeric root, and designed to provide an alternative for patients currently refractory to classical epilepsy medications. TCA-0...
